Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Apr
30
2020
ExecuPharm Data Stolen in Ransomware Attack Published on Internet Robinson & Cole LLP
Apr
30
2020
Eleventh Circuit Lawsuit Claims Bacardi Used Harmful and Illegal Additive in its Liquor Keller and Heckman LLP
Apr
30
2020
Global Supply Chains In The Wake Of COVID-19 In Socially Critical Industries – Is It Time To Reshore? Squire Patton Boggs (US) LLP
Apr
30
2020
Mary Jane and the Remote Workplace Jackson Lewis P.C.
Apr
29
2020
U.S. Supreme Court Holds Federal Government Accountable for ACA Promises Barnes & Thornburg LLP
Apr
29
2020
Pharmacy Groups Request COVID-19 Testing Authority for California Pharmacists Much Shelist, P.C.
Apr
29
2020
“Governor, Can I Take Your Order?” – Pennsylvania House Votes to Allow Mixed Drinks To-Go but Will Governor Make It Law? Norris McLaughlin P.A.
Apr
29
2020
EPA and CBP Announce the Prevention of Shipments of Unregistered “Virus Shut Out” Product Imported into California Bergeson & Campbell, P.C.
Apr
29
2020
FDA Issues Temporary Policy Regarding Certain Accredited Third-Party Certification Program Requirements During COVID-19 Keller and Heckman LLP
Apr
29
2020
COVID-19 and Lab Testing: What’s the Story Behind the Story? Mintz
Apr
28
2020
New York Employers: Engage In The Interactive Dialogue With Medical Marijuana Users Jackson Lewis P.C.
Apr
28
2020
EPA Publishes Draft Risk Evaluation of Perchloroethylene Bergeson & Campbell, P.C.
Apr
28
2020
Face or Fingerprint? The DEA Revisits Biometric Identifiers for e-Prescribing Controlled Substances Epstein Becker & Green, P.C.
Apr
28
2020
Adjusting to Alice: USPTO’s View of Its Examination Guidelines Foley & Lardner LLP
Apr
28
2020
FDA Issues Warning Letters to Companies Marketing CBD Products for Treatment of Disease and Addiction Keller and Heckman LLP
Apr
27
2020
State Departments of Agriculture are Working Together and Independently to Maintain the American Food Supply and Keep it Safe During the COVID-19 Pandemic Keller and Heckman LLP
Apr
27
2020
CMS Releases 340B Drug Acquisition Cost Survey, Responses Due May 15, 2020 McDermott Will & Emery
Apr
27
2020
Patent Strategies For Expedited Chinese Approval Of Medical Devices Schwegman, Lundberg & Woessner, P.A.
Apr
27
2020
340B Update: CMS Opens Acquisition Cost Data Survey for 340B Hospitals K&L Gates
Apr
27
2020
Navigating Employer Obligations to Provide Employees with Masks, Face Coverings Jackson Lewis P.C.
Apr
26
2020
Kraft v Bega: Australian Appeal Court Decision Reaffirms the Perils of Relying on Unregistered Trade Mark Rghts K&L Gates
Apr
26
2020
Chinese Rail System for Restaurant Meal Delivery Patent Infringed Schwegman, Lundberg & Woessner, P.A.
Apr
26
2020
HHS Announces Additional Distributions from Emergency Fund McDermott Will & Emery
Apr
26
2020
SAB to Review EPA Research on Large Scale Disinfection of COVID-19 Virus Bergeson & Campbell, P.C.
Apr
24
2020
As America Prepares to Return to Work, EEOC Approves Testing Employees for COVID-19 Sheppard, Mullin, Richter & Hampton LLP
Apr
24
2020
McDermottPLUS Check-Up: April 24, 2020 McDermott Will & Emery
Apr
24
2020
4/20 Federal Ruling: Marketer Can Be Liable For Dispensarys’ TCPA Violations Squire Patton Boggs (US) LLP
Apr
24
2020
Investors: SEC Warns to Be Aware of Uptick of Fraud in the Cannabis Industry Norris McLaughlin P.A.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins